Cargando…
Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease()
OBJECTIVE: Respiratory viruses are a common trigger for exacerbations of chronic obstructive pulmonary disease (COPD). Human metapneumovirus (hMPV) is a paramyxovirus associated with respiratory tract infections and wheezing. Our aim was to determine whether hMPV was associated with exacerbations of...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Society. Published by Elsevier Ltd.
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112509/ https://www.ncbi.nlm.nih.gov/pubmed/16412516 http://dx.doi.org/10.1016/j.jinf.2005.11.010 |
_version_ | 1783513488208953344 |
---|---|
author | Martinello, Richard A. Esper, Frank Weibel, Carla Ferguson, David Landry, Marie L. Kahn, Jeffrey S. |
author_facet | Martinello, Richard A. Esper, Frank Weibel, Carla Ferguson, David Landry, Marie L. Kahn, Jeffrey S. |
author_sort | Martinello, Richard A. |
collection | PubMed |
description | OBJECTIVE: Respiratory viruses are a common trigger for exacerbations of chronic obstructive pulmonary disease (COPD). Human metapneumovirus (hMPV) is a paramyxovirus associated with respiratory tract infections and wheezing. Our aim was to determine whether hMPV was associated with exacerbations of COPD. METHODS: The study was designed as an observational cohort study carried out in a 944-bed urban teaching hospital located in New Haven, Connecticut. Between December 2002 and May 2003, patients hospitalized due to an exacerbation of COPD were identified. Nasopharyngeal specimens obtained from these patients were tested for human metapneumovirus by RT–PCR and for respiratory syncytial virus, influenza A and B, parainfluenza-1, -2, and -3 and adenovirus by a cytospin-enhanced direct immunofluorescence assay and/or viral culture. RESULTS: Fifty individuals met enrollment criteria and hMPV was identified in 6 (12%), respiratory syncytial virus in 4 (8%), influenza A in 2 (4%) and parainfluenza type 3 in 1 (2%) patients. Both A and B hMPV genotypes were identified in patients hospitalized due to exacerbations of COPD. CONCLUSION: hMPV was frequently identified in patients hospitalized due to an exacerbation of COPD. Further studies are necessary to determine the epidemiology and the impact of hMPV in COPD patients. |
format | Online Article Text |
id | pubmed-7112509 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | The British Infection Society. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71125092020-04-02 Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease() Martinello, Richard A. Esper, Frank Weibel, Carla Ferguson, David Landry, Marie L. Kahn, Jeffrey S. J Infect Article OBJECTIVE: Respiratory viruses are a common trigger for exacerbations of chronic obstructive pulmonary disease (COPD). Human metapneumovirus (hMPV) is a paramyxovirus associated with respiratory tract infections and wheezing. Our aim was to determine whether hMPV was associated with exacerbations of COPD. METHODS: The study was designed as an observational cohort study carried out in a 944-bed urban teaching hospital located in New Haven, Connecticut. Between December 2002 and May 2003, patients hospitalized due to an exacerbation of COPD were identified. Nasopharyngeal specimens obtained from these patients were tested for human metapneumovirus by RT–PCR and for respiratory syncytial virus, influenza A and B, parainfluenza-1, -2, and -3 and adenovirus by a cytospin-enhanced direct immunofluorescence assay and/or viral culture. RESULTS: Fifty individuals met enrollment criteria and hMPV was identified in 6 (12%), respiratory syncytial virus in 4 (8%), influenza A in 2 (4%) and parainfluenza type 3 in 1 (2%) patients. Both A and B hMPV genotypes were identified in patients hospitalized due to exacerbations of COPD. CONCLUSION: hMPV was frequently identified in patients hospitalized due to an exacerbation of COPD. Further studies are necessary to determine the epidemiology and the impact of hMPV in COPD patients. The British Infection Society. Published by Elsevier Ltd. 2006-10 2006-01-10 /pmc/articles/PMC7112509/ /pubmed/16412516 http://dx.doi.org/10.1016/j.jinf.2005.11.010 Text en Copyright © 2005 The British Infection Society. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Martinello, Richard A. Esper, Frank Weibel, Carla Ferguson, David Landry, Marie L. Kahn, Jeffrey S. Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease() |
title | Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease() |
title_full | Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease() |
title_fullStr | Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease() |
title_full_unstemmed | Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease() |
title_short | Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease() |
title_sort | human metapneumovirus and exacerbations of chronic obstructive pulmonary disease() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112509/ https://www.ncbi.nlm.nih.gov/pubmed/16412516 http://dx.doi.org/10.1016/j.jinf.2005.11.010 |
work_keys_str_mv | AT martinelloricharda humanmetapneumovirusandexacerbationsofchronicobstructivepulmonarydisease AT esperfrank humanmetapneumovirusandexacerbationsofchronicobstructivepulmonarydisease AT weibelcarla humanmetapneumovirusandexacerbationsofchronicobstructivepulmonarydisease AT fergusondavid humanmetapneumovirusandexacerbationsofchronicobstructivepulmonarydisease AT landrymariel humanmetapneumovirusandexacerbationsofchronicobstructivepulmonarydisease AT kahnjeffreys humanmetapneumovirusandexacerbationsofchronicobstructivepulmonarydisease |